FMO5 and amyotrophic lateral sclerosis: Elevated ROS levels have been observed in ALS‐MNs, with reported causative factors including mitochondrial abnormalities, elevated NADPH oxidase activity and expression, and irregularities in the NRF2 pathway (Cunha‐Oliveira et al. 2020; Motataianu et al. 2022).